Trial intelligence / Profile preview

Ciprofol versus propofol for induction and maintenance of general anesthesia in day-case surgery

ChiCTR2100052635Phase 4Recruiting

Sponsor
The Second Affiliated Hospital of Nanchang University
Start
Nov 2021
Modality
Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, single-blind trial of ciprofol in Not applicable (2 arms), sponsored by The Second Affiliated Hospital of Nanchang University. Primary endpoint: Ratio of successful induction and maintenance of anesthesia. Started Nov 2021; status: recruiting.

02

Drugs

ciprofol
03

Conditions

Not applicable

Beyond the preview

Go deeper on ChiCTR2100052635.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100052635.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call